NCT06300788

Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease

Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease - PPi-DIA

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Centre Hospitalier Universitaire de Nice · Academic / Other
• Sex: All
• Age: 0 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

The investigator aim to identify the role of inorganic pyrophosphate and other anti-calcifying molecules in vascular disease in children with chronic kidney disease, with a view to developing therapeutic approaches aimed at limiting the onset of vasculopathy.

Detailed description

The study of pro- and anti-calcifying molecules in children with chronic kidney disease will be carried out using dosages made on serum in comparison with the dosage of these same molecules in control children matched according to age and sex. without chronic kidney disease. An evaluation of vascular function by clinical (auscultation, palpation) and ultrasound techniques (measurement of intima-media thickness and measurement of pulse wave velocity) will also be carried out in children with chronic kidney disease and compared to norms of children without chronic kidney disease. These evaluations aim to improve understanding of the pathophysiology of vascular calcification and thus open up therapeutic perspectives in these children.

Conditions

• Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control

Interventions

Type	Name	Description
OTHER	PPI and T50 dosing	Sampling for PPI determination and T50 in blood and urine.

Timeline

• Start date: 2024-05-27
• Primary completion: 2026-11-27
• Completion: 2026-11-27
• First posted: 2024-03-08
• Last updated: 2025-07-10

Locations

1 site across 1 country: France